Device Trial Radar · NCT03218423
Longitudinal Performance of Epi proColon
Last checked: Nov 19, 2026Latest source record: Nov 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
4,500
Planned (sponsor's estimate)
Start
Aug 18, 2017
Primary completion
Aug 2023
Study completion Jan 2024
Sponsor
- Lead sponsor
- Epigenomics, IncNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 14, 2017
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 50 years, up to 74 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study will evaluate longitudinal performance of Epi proColon with respect to test positivity, longitudinal adherence to Epi proColon screening, adherence to follow-up colonoscopy and diagnostic yield, as well as assay failure rates.
Conditions
- Colorectal Cancer
- Colorectal Neoplasms
Interventions
Epi proColonDevice
Plasma cell free DNA SEPT9 promoter methylation test for colorectal cancer screening.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The difference in test specificity between initial testing and repeat testing 1 yearTime frame: Through study completion, expected at 60 months
- Detection of colorectal cancerTime frame: Through study completion, expected at 60 months
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Veterans Affairs San Diego Healthcare System
San Diego, California · Recruiting
Beaumont Health System
Royal Oak, Michigan · Recruiting
Rutgers University Hospital
New Brunswick, New Jersey · Recruiting
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.